News
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.
2h
Zacks Investment Research on MSNEli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
FAT jabs have taken the world by storm, offering millions of people with excess weight a chance of a new life. The ‘King Kong ...
Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...
The NHS has approved medications such as Mounjaro and Wegovy to tackle obesity and diabetes, with private prescriptions also ...
Jordan Bateman, 31, found himself relying on fast food from service stations as he travelled the UK working as an entertainer-and it soon caught up with him.
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
Zealthy now offers nationwide virtual care, expanding access to personalized women’s health, GLP-1 medications, and lifestyle coaching. NEW YORK, NY, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- ...
Presented by AstraZeneca{beacon} Health Care Health Care The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
A doctor has revealed 'maintaining nutrition' while on weight-loss drugs like Mounjaro is 'crucial' for long-term health amid worrying survey results.
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results